Myleran

Product manufactured by Aspen Global Inc.

Application Nr Approved Date Route Status External Links
NDA009386 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications
Indications And Usage Myleran (Busulfan) Is Indicated For The Palliative Treatment Of Chronic Myelogenous (Myeloid, Myelocytic, Granulocytic) Leukemia.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Busulfan BUSULFAN ZINC1530572

Comments